Lake Street Advisors Group LLC Has $228,000 Position in Haleon plc (NYSE:HLN)

Lake Street Advisors Group LLC grew its holdings in Haleon plc (NYSE:HLN) by 25.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,161 shares of the company’s stock after purchasing an additional 5,533 shares during the quarter. Lake Street Advisors Group LLC’s holdings in Haleon were worth $228,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in HLN. Barclays PLC grew its holdings in Haleon by 56.4% in the second quarter. Barclays PLC now owns 3,317 shares of the company’s stock worth $28,000 after purchasing an additional 1,196 shares during the period. Hollencrest Capital Management boosted its position in shares of Haleon by 21.5% during the 1st quarter. Hollencrest Capital Management now owns 7,114 shares of the company’s stock worth $58,000 after purchasing an additional 1,258 shares in the last quarter. Apollon Wealth Management LLC grew its stake in shares of Haleon by 11.0% in the 1st quarter. Apollon Wealth Management LLC now owns 13,404 shares of the company’s stock valued at $109,000 after buying an additional 1,332 shares during the period. O Shaughnessy Asset Management LLC increased its position in Haleon by 11.3% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 15,320 shares of the company’s stock valued at $125,000 after buying an additional 1,551 shares in the last quarter. Finally, Advisor Partners II LLC raised its stake in Haleon by 3.7% during the 4th quarter. Advisor Partners II LLC now owns 44,841 shares of the company’s stock worth $359,000 after buying an additional 1,604 shares during the period. Institutional investors own 6.67% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on HLN. Morgan Stanley started coverage on Haleon in a report on Wednesday, November 1st. They set an “overweight” rating for the company. Investec upgraded shares of Haleon from a “sell” rating to a “hold” rating in a research note on Tuesday, August 8th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $364.00.

Haleon Stock Performance

Shares of Haleon stock remained flat at $8.25 on Friday. The stock had a trading volume of 2,910,553 shares, compared to its average volume of 4,453,054. Haleon plc has a 12-month low of $6.67 and a 12-month high of $9.05. The company has a quick ratio of 0.54, a current ratio of 0.84 and a debt-to-equity ratio of 0.53. The stock’s 50-day simple moving average is $8.19 and its 200 day simple moving average is $8.32.

Haleon (NYSE:HLN) last released its quarterly earnings results on Thursday, November 2nd. The company reported $0.10 EPS for the quarter. The company had revenue of $3.54 billion during the quarter. Equities analysts anticipate that Haleon plc will post 0.44 earnings per share for the current fiscal year.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.